For the Inventor, By the Inventor

Enter assignee name

Gaithersburg, MD, United States of America

Biosynexus, Inc.

USPTO Granted Patents = 13

% Expired Patents = 100.0

CIPO Patents = 1

EPO Patents = 4

Forward Citations = 84

Loading Chart...

Loading Chart...

18 inventors (with patents filed for the assignee):

James J Mond (9 out of 38 patents)

Scott Michael Walsh (5 out of 6 patents)

Andrew Lees (4 out of 30 patents)

4. Richard F Schuman (4 out of 15 patents)

5. Simon J Foster (4 out of 13 patents)

6. Jeffrey R Stinson (4 out of 13 patents)

7. Gerald Walter Fischer (4 out of 54 patents)

8. Philip McDowell (3 out of 3 patents)

9. Simon Clarke (3 out of 3 patents)

10. Mary Catherine Pittaway (3 out of 3 patents)

11. Kirsty Brummell (2 out of 2 patents)

12. Anjali G Shah (2 out of 2 patents)

13. John Fitzgerald Kokai-Kun (2 out of 2 patents)

14. Hing C Wong (1 out of 110 patents)

15. Julie M Adams (1 out of 1 patent)

13 patents: Sort by Forward Citations

1. 8697639 - Compositions and methods for treating bacteria (2014-04-15),

2. 8568731 - [object Object] (2013-10-29),

3. 8372958 - Opsonic and protective monoclonal and chimeric antibodies specific for lipoteichoic acid of gram posiive bacteria (2013-02-12),

4. 7777017 - Nucleic acids encoding opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of gram positive bacteria (2010-08-17),

5. 7585658 - Staphylococcus aureus antigenic polypeptides and compositions (2009-09-08),

6. 7576054 - Compositions and methods for treating bacteria (2009-08-18),

7. 7572439 - Enzyme disruption of bacterial biofilms (2009-08-11),

8. 7517852 - Compositions and methods for treating bacteria (2009-04-14),

9. 7452533 - Antimicrobial polymer conjugate containing lysostaphin and polyethylene glycol (2008-11-18),

10. 7410647 - Antigenic polypeptides (2008-08-12),

11. 7250494 - Opsonic monoclonal and chimeric antibodies specific for lipoteichoic acid of Gram positive bacteria (2007-07-31),

12. 7169903 - Multifunctional monoclonal antibodies directed to peptidoglycan of gram-positive bacteria (2007-01-30),

13. 7166708 - Process for preparing conjugate vaccines and the conjugate vaccines (2007-01-23),

Biosynexus, Inc. is a biopharmaceutical company focused on developing innovative therapeutics to address unmet medical needs. Leveraging our proprietary technology platform, we specialize in the design and development of targeted therapies for various diseases. Our mission is to improve patient outcomes by advancing novel treatment options. Visit our website to learn more about our groundbreaking research and pipeline of potential therapeutics.

Profile summary based on public USPTO records.

Company Badge

USPTO Data Jan 1 1976 - Sep 29 2026

13 Patents

#38 in Gaithersburg, MD

#330 in Maryland

#23,808 in US

#44,950 in the World

Gaithersburg, MD, United States of America

Biosynexus, Inc.

Forward Citations = 84

18 inventors:

James J Mond (9 out of 38 patents)

Scott Michael Walsh (5 out of 6 patents)

Andrew Lees (4 out of 30 patents)

4. Richard F Schuman (4 out of 15 patents)

5. Simon J Foster (4 out of 13 patents)

Please report any incorrect information to [email protected]

Loading…